Paper28577973
Membrane-lipid therapy: A historical perspective of membrane-targeted therapies - From lipid bilayer structure to the pathophysiological regulation of cells.
Escribá PV. Biochim Biophys Acta Biomembr, 2017. Cited by 70 papers, by iCite.
Cite this record
ConductScience Library. Membrane-lipid therapy: A historical perspective of membrane-targeted therapies - From lipid bilayer structure to the pathophysiological regulation of cells. Papers, record 28577973. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28577973
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Membrane-lipid therapy: A historical perspective of membrane-targeted therapies - From lipid bilayer structure to the pathophysiological regulation of cells.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cell Membrane | Major topic |
| Lipid Bilayers | Major topic |
| Membrane Lipids | Major topic |
| Drug Design | |
| Humans | |
| Inflammation | |
| Metabolic Diseases | |
| Neoplasms | |
| Neurodegenerative Diseases |
Source PubMed
Cited by48
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 70 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42353023 | Statins in Membrane Lipid Therapy: Mechanistic Promise Versus Clinical Reality. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42353023 | PubMed |
| 42001082 | Mechanobiology of cancer-associated thrombosis: from molecular mechanisms to therapeutic innovation. | J Nanobiotechnology | 2026 | https://conductscience.org/library/papers/42001082 | PubMed |
| 41754366 | Structural Insights into Cell Wall-Related Vesicle Secretion with Different Mechanisms. | Plants (Basel) | 2026 | https://conductscience.org/library/papers/41754366 | PubMed |
| 41699650 | Cetoleic acid and other long-chain unsaturated fatty acids as neuroprotective nutraceuticals. | Lipids Health Dis | 2026 | https://conductscience.org/library/papers/41699650 | PubMed |
| 41001973 | Effects of Ethanol and Opioid Receptor Antagonists Naltrexone and LY2444296 on the Organization of Cholesterol- and Sphingomyelin-Enriched Plasma Membrane Domains. | ACS Chem Neurosci | 2025 | https://conductscience.org/library/papers/41001973 | PubMed |
| 40783537 | Global variations in omega-3 fatty acid status and omega-6:omega-3 ratios: insights from > 500,000 whole-blood dried blood spot samples. | Lipids Health Dis | 2025 | https://conductscience.org/library/papers/40783537 | PubMed |
| 40097723 | Preclinical assessment of a ganglioside-targeted therapy for Parkinson's disease with the first-in-class adaptive peptide AmyP53. | Sci Rep | 2025 | https://conductscience.org/library/papers/40097723 | PubMed |
| 40076912 | Xanthohumol Sensitizes Melanoma Cells to Vemurafenib by Lowering Membrane Cholesterol and Increasing Membrane Fluidity. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40076912 | PubMed |
| 39956817 | Targeting ELOVL6 to disrupt c-MYC driven lipid metabolism in pancreatic cancer enhances chemosensitivity. | Nat Commun | 2025 | https://conductscience.org/library/papers/39956817 | PubMed |
| 39620135 | Fatty acid abnormalities in cystic fibrosis-the missing link for a cure? | iScience | 2024 | https://conductscience.org/library/papers/39620135 | PubMed |
| 39400678 | Targeting the Notch-Furin axis with 2-hydroxyoleic acid: a key mechanism in glioblastoma therapy. | Cell Oncol (Dordr) | 2025 | https://conductscience.org/library/papers/39400678 | PubMed |
| 39180473 | Influence of Simvastatin and Pravastatin on the Biophysical Properties of Model Lipid Bilayers and Plasma Membranes of Live Cells. | ACS Biomater Sci Eng | 2024 | https://conductscience.org/library/papers/39180473 | PubMed |
| 38898145 | Randomised, double-blind, placebo-controlled, parallel-group, multicentric, phase IIA clinical trial for evaluating the safety, tolerability, and therapeutic efficacy of daily oral administration of NFX88 to treat neuropathic pain in individuals with spinal cord injury. | Spinal Cord | 2024 | https://conductscience.org/library/papers/38898145 | PubMed |
| 38892406 | Tumor-Homing Peptides as Crucial Component of Magnetic-Based Delivery Systems: Recent Developments and Pharmacoeconomical Perspective. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38892406 | PubMed |
| 38257890 | Research Advances on the Role of Lipids in the Life Cycle of Human Coronaviruses. | Microorganisms | 2023 | https://conductscience.org/library/papers/38257890 | PubMed |
| 37488446 | A Phase 1/2A trial of idroxioleic acid: first-in-class sphingolipid regulator and glioma cell autophagy inducer with antitumor activity in refractory glioma. | Br J Cancer | 2023 | https://conductscience.org/library/papers/37488446 | PubMed |
| 37242505 | 2-Hydroxyoleic Acid as a Self-Assembly Inducer for Anti-Cancer Drug-Centered Nanoparticles. | Pharmaceuticals (Basel) | 2023 | https://conductscience.org/library/papers/37242505 | PubMed |
| 37082601 | Regulation and functions of membrane lipids: Insights from Caenorhabditis elegans. | BBA Adv | 2022 | https://conductscience.org/library/papers/37082601 | PubMed |
| 36831093 | Structural Basis of the Interaction of the G Proteins, Gαi1, Gβ1γ2 and Gαi1β1γ2, with Membrane Microdomains and Their Relationship to Cell Localization and Activity. | Biomedicines | 2023 | https://conductscience.org/library/papers/36831093 | PubMed |
| 36077299 | HCA (2-Hydroxy-Docosahexaenoic Acid) Induces Apoptosis and Endoplasmic Reticulum Stress in Pancreatic Cancer Cells. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36077299 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28577973
GET https://conductscience.org/api/papers/v1/28577973/cited_by?page=2